Further, baicalein strongly downregulates miR-106, which targets p21/WAF1 to inhibit JNK, MAPK kinase (MEK), and ERK in T24 bladder cancer cells (54). The gene discussed is CDKN1A; the disease is urinary bladder carcinoma.